Clinical trial
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg…
NCT00352183 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00352183 |
|---|---|
| Title | Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy |
| Official title | A Multicenter, Double-Blind, Randomized Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 40 mg Simvastatin With 40 mg Simvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 40 mg Simvastatin… |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Fenofibrate/Simvastatin, Simvastatin |
| Enrollment | 450 |
| Start date | Jan 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 14, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | Australia, Estonia, Hungary, Latvia, Lithuania, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: